On this episode of The Whole View podcast, Stacy and I continue our never-ending series on Covid-19! (*insert laughing, but really crying emoji here*) The emergence of the Omicron variant has truly changed the game the last couple of months, and I dive into what the latest science says, keeping in mind that the body of evidence is growing by the day! New studies have shown that the R0 value for this variant (reminder that is a measure of the transmissibility of a virus), could be the second, if not the first most contagious virus ever in history. It rivals measles in competing for that top most-contagious-ever spot. The research has shown that this insane transmissibility is not due to a higher viral load than other variants, but is shown to spread as effectively between twice-vaccinated and unvaccinated people. Yet another reason why there is a big push to get boosted, to add that additional protection.
Table of Contents[Hide][Show]
However, the vaccines continue to do their job, even with the numerous mutations of Omicron, and are preventing serious illness and death on a large scale. There have been many anecdotes and questions about the accuracy of rapid tests, and the data shows that if you are going to do a rapid test, they are the most accurate around day 3-5 of symptoms. Omicron also has a very short incubation period when compared to the previous variants (Omicron’s is as short as 33 hours in some studies, before exposure leads to symptoms). Additionally perplexing and further hampering the prevention of spread is that symptoms of Omicron are not necessarily typical of other variants. Symptoms such as headache and a runny nose that were previously not prevalent in other variants, are very common for Omicron. As of recording this podcast there is a 50/50 chance that if you have cold-like symptoms of any kind, it is Omicron. One of the most important things we discuss in this podcast is the harmful idea that Omicron is “mild”. Stacy and I discuss the difference between “less severe” and “mild” and how calling Omicron mild is a very dangerous thing to be purporting.
If you enjoy the show, please review it on iTunes
Recommended Reading and Listening
- The Covid-19 mRNA Vaccines
- TWV Podcast Episode 440: Covid-19 Vaccines Part 1 – mRNA Vaccine Technology
- TWV Podcast Episode 441: Covid-19 Vaccines Part 2 – Pfizer/BioNTech vs Moderna
- TWV Podcast Episode 443: Covid-19 Vaccines Part 3 – FAQs
- TWV Podcast Episode 444: Covid-19 Vaccines Part 4 – Myth Busing
- TWV Podcast Episode 454: J&J and AstraZeneca Covid-19 Vaccines
- TWV Podcast Episode 455: Covid-19 Vaccines – Real World Data and Updated Studies
- TWV Podcast Episode 468: The Delta Covid-19 Variant
- TWV Podcast Episode 485: Covid-19 Boosters for Adults
- TWV Podcast Episode 486: Covid-19 Vaccines for Children
Citations
Pronouncing ‘Omicron’: ‘AH-muh-cron’ or ‘Oh-MY-cron’?
COVID Data Tracker Weekly Review | CDC
Understanding the Omicron variant’s mutations – The Washington Post
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Omicron variant and booster COVID-19 vaccines
SARS-CoV-2 Omicron VOC Transmission in Danish Households
Initial Assessment of SARS-CoV-2 Omicron Variant in Exhaled Breath Aerosol
Save 70% Off the AIP Lecture Series!
Learn everything you need to know about the Autoimmune Protocol to regain your health!
I am loving this AIP course and all the information I am receiving. The amount of work you have put into this is amazing and greatly, GREATLY, appreciated. Thank you so much. Taking this course gives me the knowledge I need to understand why my body is doing what it is doing and reinforces my determination to continue along this dietary path to heal it. Invaluable!
Carmen Maier
SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion | bioRxiv
If you’ve been exposed to the coronavirus – Harvard Health
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron | medRxiv
What we know about the Omicron COVID-19 variant so far
SARS-CoV-2 variants of concern and variants under investigation
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
Omicron infection enhances neutralizing immunity against the Delta variant